9 Things to Know About Glycine as a Sleep and Anxiety Supplement in Perimenopause
The 3 a.m. wide-awake thing felt like a personal failing for a long time — like a brain that simply wouldn't cooperate. Learning that there's a physiological reason the body runs hot and hypervigilant at night, and that something as unglamorous as an amino acid might help, was quietly revolutionary. It won't fix everything, but it's the kind of lead worth following.
Learn more about Rose →Glycine Is an Amino Acid the Body Already Makes — but May Need More Of
Glycine is the simplest amino acid and is synthesized endogenously, primarily in the liver, from serine and other precursors. During periods of physiological stress — including the hormonal upheaval of perimenopause — demand for glycine can outpace what the body produces on its own. Supplementing with glycine (typically 3 g taken before bed) is considered safe and well-tolerated, with no significant dependency or rebound effects documented in trials to date.
It Lowers Core Body Temperature Through a Distinct Vascular Mechanism
One of glycine's most relevant actions for perimenopausal women is its ability to reduce core body temperature at sleep onset by promoting peripheral vasodilation — essentially redirecting heat away from the body's core toward the skin surface. This mirrors the natural thermoregulatory drop that healthy sleep initiation requires, a process that estrogen decline disrupts significantly. In a small but rigorously designed Japanese trial, participants taking 3 g glycine before bed showed measurable reductions in core temperature alongside faster sleep onset.
It Acts on NMDA Receptors to Quiet Neurological Hyperarousal
Glycine functions as a co-agonist at NMDA glutamate receptors in the central nervous system, which plays a role in modulating excitatory signalling — the kind of persistent neural activation that keeps the perimenopausal brain buzzing when it should be winding down. By influencing this pathway, glycine may help reduce the hyperarousal state that many women describe as lying awake with a busy, unquietable mind. This is a mechanistically distinct action from sedative supplements like valerian or melatonin, which is why some researchers consider it a genuinely novel sleep target.
It Also Acts as an Inhibitory Neurotransmitter in the Spinal Cord and Brainstem
Beyond its NMDA co-agonist role, glycine is itself an inhibitory neurotransmitter, binding to strychnine-sensitive glycine receptors in the spinal cord and brainstem to dampen sensory and motor signalling. This dual role — calming both excitatory and inhibitory circuits depending on the receptor type — gives it a broader neurological footprint than most single-mechanism sleep aids. For women whose sleep disruption involves physical restlessness or heightened sensory sensitivity, this pathway may be particularly relevant.
Human Trials Show Improved Subjective Sleep Quality Without Next-Day Sedation
A key study published in Sleep and Biological Rhythms found that participants taking 3 g glycine before bed reported significantly reduced fatigue, improved sleep satisfaction, and better daytime alertness compared to placebo — without the grogginess that accompanies many sedative supplements. Polysomnography data from a parallel study showed glycine reduced time to slow-wave sleep, the deepest and most restorative stage, which is frequently curtailed in perimenopausal women. The absence of a sedative hangover makes it practically different from options like antihistamines or benzodiazepines.
The Anxiety-Reducing Effects Are Real but Modest and Indirect
Glycine's anxiolytic potential comes primarily from its inhibitory neurotransmitter activity and its influence on the stress-response axis rather than from any direct GABA-mimetic action. Animal studies show consistent anxiolytic effects; human data is more limited but supports a gentle calming effect that is particularly relevant when anxiety is sleep-disrupting rather than clinically severe. Women dealing with the specific cocktail of nighttime anxiety and wakefulness — rather than generalised daytime anxiety disorder — appear to be the most relevant target population in the existing research.
Timing and Dose Matter: The Evidence Points to 3 g, Thirty Minutes Before Bed
The trials that produced positive sleep outcomes used a consistent protocol: 3 grams of glycine taken orally approximately 30 minutes before sleep. This dose is well below any threshold associated with adverse effects — glycine is used intravenously in far larger quantities in surgical settings — and is typically available as an unflavoured powder that dissolves easily in water. There is no strong evidence that higher doses produce better outcomes, and the research base has not yet examined whether timing adjustments (e.g., earlier in the evening) alter efficacy.
It May Complement Magnesium Glycinate — but They Are Not the Same Thing
Magnesium glycinate is a chelated form of magnesium where magnesium is bound to glycine for improved absorption, and it is often recommended for perimenopausal sleep issues because of magnesium's own muscle-relaxing and nervous-system-calming properties. However, the glycine content delivered via a standard magnesium glycinate dose is significantly lower than the 3 g used in glycine-specific sleep trials, so the two supplements address partially overlapping but not identical mechanisms. Taking both is not contraindicated, but it is worth understanding that magnesium glycinate is not a substitute for glycine supplementation if the goal is the temperature-regulation and NMDA-modulation effects described in the research.
Glycine Is Not a Replacement for Addressing Hormonal Root Causes
The sleep disruption and thermoregulatory instability that glycine targets are downstream effects of declining estrogen and progesterone — and glycine does not address those hormonal shifts directly. For women whose symptoms are significantly impacting quality of life, glycine is best understood as a supportive tool that may ease the nightly burden while broader conversations about hormone therapy or other evidence-based interventions are explored. It is a genuinely useful option, but thinking of it as a standalone solution risks missing the larger physiological picture.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.